|
Apr 24
|
Bristol Myers Reports Better-Than-Expected Earnings. The Future Is Cloudy.
|
|
Apr 24
|
Bristol Myers Squibb Reverses Its Losing Spree On First-Quarter Beat
|
|
Apr 24
|
Dividends Could Be Under Threat. Here Are 9 Stocks With Safe 5% Yields.
|
|
Apr 24
|
Bristol-Myers Squibb (NYSE:BMY) Raises 2025 Revenue Guidance Following Strong Q1 Performance
|
|
Apr 24
|
Netflix's new high, Bristol Myers outlook, Texas Instruments pops
|
|
Apr 24
|
Bristol Myers Delivers Upbeat 2025 Forecast Despite China Tariffs Impact
|
|
Apr 24
|
BMY Beats on Q1 Earnings and Sales, Raises 2025 Outlook
|
|
Apr 24
|
Compared to Estimates, Bristol Myers (BMY) Q1 Earnings: A Look at Key Metrics
|
|
Apr 24
|
Drugmakers brace for Trump tariffs, while weighing numerous other worries
|
|
Apr 24
|
Bristol Myers says schizophrenia drug launch ‘off to a solid start’
|
|
Apr 24
|
Bristol Myers Squibb (BMY) Surpasses Q1 Earnings and Revenue Estimates
|
|
Apr 24
|
Bristol-Myers Squibb (NYSE:BMY) Reports Upbeat Q1, Full-Year Outlook Slightly Exceeds Expectations
|
|
Apr 24
|
Bristol Myers: Q1 Earnings Snapshot
|
|
Apr 24
|
Bristol Myers posts higher-than-expected quarterly revenue on cancer drug sales
|
|
Apr 24
|
Bristol Myers Squibb Reports First Quarter Financial Results for 2025
|
|
Apr 23
|
These Stocks Moved the Most Today: Tesla, Intel, Enphase, Bristol Myers, Boeing, AT&T, and More
|
|
Apr 23
|
Biotech Stock Roundup: BMY Down on Study Data, Updates From REGN & More
|
|
Apr 23
|
Bristol Myers Stock Falls As Schizophrenia Trial Failure Dims Outlook
|
|
Apr 23
|
Is Bristol-Myers Squibb Company (BMY) the Best Stock That Will Always Grow?
|
|
Apr 23
|
Bristol Myers' Cobenfy Falls Short On Primary Endpoint In Phase 3 Schizophrenia Trial, Stock Slides
|